ArticleNeurological research and practice2021

Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19.

Max Borsche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.